So-Young to Report Third Quarter 2025 Financial Results on November 17, 2025

So-Young International Inc. (NASDAQ: SY), a prominent aesthetic treatment platform in China, is set to release its financial results for the third quarter of 2025 on November 17, 2025. The announcement comes just before U.S. markets open, underscoring the importance of its fiscal performance to investors. So-Young, renowned for connecting consumers with a range of aesthetic services, offers insights into treatment options through its digital platform and operates numerous branded treatment centers.

The management team will host an earnings conference call on the same day at 7:00 AM U.S. Eastern Time, providing an opportunity for stakeholders to gain insight into the company's performance and strategic direction. Investors can join the call using various international and local dial-in numbers, ensuring accessibility for diverse participants. For those unable to attend the live presentation, a replay will be available shortly after the call concludes.

So-Young's business model leverages its strong brand recognition, extensive digital reach, and a well-structured supply chain, enabling it to deliver affordable and high-quality treatments. As it strives to expand along the medical aesthetic value chain, the upcoming financial report is anticipated to shed light on the company's growth trajectory and market position.

For additional details, interested parties may access a live and archived webcast of the call through So-Young's investor relations website, reinforcing transparency and engagement with their investment community. The announcement emphasizes So-Young’s commitment to providing timely updates on their financial health and business outlook as they continue to evolve within the competitive landscape of aesthetic treatments in China.

As So-Young International Inc. (NASDAQ: SY) prepares to announce its third-quarter financial results for 2025 on November 17, investors should closely examine several factors that could influence the company’s performance and stock movement.

So-Young is positioned at the forefront of China's booming aesthetic treatment market, offering a platform that seamlessly connects consumers with both online services and offline treatment facilities. The rising demand for aesthetic procedures in China, coupled with the company’s strong digital presence, gives it a competitive edge in a sector that is expected to continue its steady growth.

As we approach the earnings release, investors should focus on key metrics that So-Young may provide, such as revenue growth, user acquisition costs, and operating margins. Any indications of increased customer engagement or expanded partnerships with aesthetic clinics could signal robust growth prospects. Furthermore, updates on supply chain efficiencies or technological advancements in their product offerings could play significant roles in shaping investor sentiment.

However, it’s essential to remain vigilant about potential macroeconomic challenges. The overall economic environment in China, regulatory changes in the healthcare sector, and consumer spending trends may affect So-Young’s growth trajectory. Investors should also take note of how So-Young navigates competitive pressures from both local players and global brands expanding into the Chinese market.

In summary, expect volatility around the earnings report, characterized by market reactions to performance data and broader economic signals. Assessing So-Young's ability to capitalize on market trends while managing risks will be crucial for investors considering positions in the stock before and after the November 17 announcement. Keeping an eye on analyst expectations and market responses post-release will provide further insight into the company’s future potential.